Prognostic value of matrix metalloproteinase 9 expression in patients with juvenile nasopharyngeal angiofibroma:

Xicai Sun1, Limin Guo1, Jingjing Wang1

  • 1Department of Otolaryngology, Eye, Ear, Nose and Throat Hospital, Shanghai Medical College, Fudan University, Shanghai, China.

Abstract

Insights

High expression of matrix metalloproteinase-9 (MMP-9) in juvenile nasopharyngeal angiofibroma (JNA) indicates a higher risk of tumor recurrence after surgery. MMP-9 levels correlate with patient age and serve as a prognostic indicator for JNA.

Area of Science:

  • Oncology
  • Pathology
  • Biochemistry

Background:

  • Juvenile nasopharyngeal angiofibroma (JNA) is a benign tumor with aggressive local growth and high recurrence rates.
  • Understanding molecular markers associated with JNA progression is crucial for predicting patient outcomes.

Purpose of the Study:

  • To investigate the expression and localization of matrix metalloproteinase-9 (MMP-9) in JNA.
  • To determine the correlation between MMP-9 expression and clinicopathological features, including tumor recurrence.

Main Methods:

  • Immunohistochemistry was used to assess MMP-9 expression in JNA tissue microarrays from 70 patients and 10 controls.
  • Statistical analyses, including Spearman correlation, multivariate analysis, and ROC curve analysis, were performed.

Main Results:

  • MMP-9 was detected in JNA cells and stromal cells, but not in mature vascular endothelial cells.
  • Higher MMP-9 expression correlated with a significantly higher recurrence rate in JNA patients.
  • MMP-9 expression was negatively correlated with patient age.

Conclusions:

  • Elevated MMP-9 expression is a significant poor prognostic factor for surgically treated JNA.
  • MMP-9 serves as a valuable biomarker for predicting tumor recurrence in JNA.

Related Concept Videos